March 2, 2026

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 50.49% Potential Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents an intriguing opportunity. With a market capitalization of $12.89 billion,..

Natera, Inc. (NTRA) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA), a pioneering player in the diagnostics and research sector, presents an intriguing opportunity for investors seeking growth in the healthcare industry. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Riding the Wave of a 64.85% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) is a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.72 billion, this..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 7.41% Upside in the Healthcare Sector

As an investor in the healthcare sector, keeping an eye on Alcon Inc. (ALC) could be a prudent move. With a market capitalization of $43.58 billion,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 15.60% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is capturing investor attention with its promising portfolio of RNA-targeted therapies and a potential..

Waters Corporation (WAT) Investor Outlook: Evaluating a Potential 24.63% Upside

Waters Corporation (NYSE: WAT), a leader in the healthcare sector’s diagnostics and research industry, is making waves with its analytical workflow solutions across Asia, the Americas,..

Waystar Holding Corp. (WAY) Stock Analysis: Capitalize on a 44.25% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY) is steadily positioning itself as a significant player in the healthcare technology arena, offering a compelling investment opportunity for those keen..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 32% Potential Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is proving to be a compelling investment opportunity within the healthcare sector, boasting a significant potential upside of 32.12% according to the..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a stalwart in the healthcare sector, is capturing investor attention with its robust portfolio of diagnostic and therapeutic products. With a..

ResMed Inc. (RMD) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector specializing in medical instruments and supplies, offers investors an intriguing opportunity with a potential upside..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Challenges with a Diverse Vaccine Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has generated considerable attention for its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge,..

Bio-Techne Corp (TECH) Stock Analysis: Potential 27.54% Upside Amidst Market Challenges

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector, specializes in biotechnology with a focus on life science reagents, instruments, and services. The Minneapolis-based..

Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential

Individual investors eyeing opportunities in the healthcare sector should consider Chemed Corp (CHE), a stalwart in the medical care facilities industry. With a substantial market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is capturing the attention of investors with its innovative approach in the diagnostics and research sector...

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a stalwart in the healthcare sector, offers a compelling investment opportunity for those looking to add a European pharmaceutical powerhouse to their portfolio...

Palm oil pushes higher as energy and rival oils tighten the market

Palm oil has reached a one week high as strength in rival oils and energy markets sharpens investor focus on supply, policy and positioning...

Sanofi (SNY) Stock Analysis: Exploring an 18.53% Potential Upside in the Healthcare Sector

Sanofi (SNY), a French multinational pharmaceutical giant, is a significant player in the healthcare industry, particularly within the drug manufacturing sector. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 20% Upside Potential in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, is attracting investor attention due to its potential upside..

European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance

JPMorgan European Discovery Trust plc outperformed its benchmark in January 2026, supported by strong contributions from Danieli and Kitron. While positions in Unipol and Temenos weighed..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a Promising 40.78% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotech sector, not only for its innovative approach to tackling cancer but also for its impressive..

Search

Funds

March 2, 2026

Palm oil pushes higher as energy and rival oils tighten the market

Palm oil has reached a one week high as strength in rival oils and energy markets sharpens investor focus on supply, policy and positioning...

European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance

JPMorgan European Discovery Trust plc outperformed its benchmark in January 2026, supported by strong contributions from Danieli and Kitron. While positions in Unipol and Temenos weighed on returns, the trust highlights continued support from monetary and fiscal stimulus across Europe...
Search

Funds

March 2, 2026

FTSE 100

Funds